Using the germline Cd177-KO mice17, we found that Cd177-deficiency led to a significant decrease in tumor growth from the Py8119 orthotopic breast cancer model (Fig. 5a, female mice) or the MC38 colon cancer model (Fig. 5b, male mice). The gene discussed is CD177; the disease is neoplasm.